THE ROLE OF ALDOSTERONE EXCESS IN THE DEVELOPMENT OF CARDIOVASCULAR AND METABOLIC DISORDERS
Keywords:
aldosterone, primary aldosteronism, hypertension, mineralocorticoid receptor, hypokalemia, adrenal gland, cardiovascular risk, endocrinology.Abstract
Aldosterone is a mineralocorticoid hormone produced by the zona glomerulosa of the adrenal cortex and plays an essential role in sodium balance, potassium homeostasis, extracellular fluid volume, and blood pressure regulation. Excessive aldosterone secretion can lead to significant cardiovascular, renal, and metabolic disturbances. The aim of this study was to analyze the pathophysiological mechanisms and clinical consequences of aldosterone excess, with particular attention to primary aldosteronism. A literature-based analytical approach was used to evaluate the renin-angiotensin-aldosterone system, mineralocorticoid receptor signaling, renal sodium reabsorption, potassium excretion, vascular remodeling, myocardial fibrosis, insulin resistance, and diagnostic principles. The analysis indicates that chronic aldosterone excess promotes sodium retention, volume expansion, hypertension, hypokalemia, endothelial dysfunction, vascular stiffness, left ventricular hypertrophy, myocardial fibrosis, and increased cardiovascular risk. Aldosterone may also contribute to metabolic abnormalities through oxidative stress, inflammation, and impaired insulin signaling. Primary aldosteronism is now recognized as one of the most important potentially treatable causes of secondary hypertension. Accurate diagnosis requires appropriate screening using the aldosterone-to-renin ratio, confirmatory testing where indicated, adrenal imaging, and subtype evaluation. Treatment with mineralocorticoid receptor antagonists or adrenal surgery can significantly reduce cardiovascular risk. Understanding aldosterone biology is therefore essential for modern endocrine and cardiovascular medicine.
References
1.Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment. Journal of Clinical Endocrinology & Metabolism. 2016;101(5):1889–1916.
2.Скворцова, Л. А., Махмудов, Д. Э., Усманов, Д. Р., Адылходжаев, А. А., & Хегай, Л. Н. (2019). АСПЕКТЫ СПОРТИВНОЙ АДАПТОЛОГИИ ПРИ ИЗУЧЕНИИ ВИТАМИНА D 25 (OH) D У ФУТБОЛИСТОВ. In От фундаментальных знаний к тонкому владению скальпелем (pp. 51-54).
3.Хегай, Л. Н., Скворцова, Л. А., Махмудов, Д. Э., Усманов, Д. Р., Муслимов, О. Я., & Адылходжаев, А. А. (2019). СОДЕРЖАНИЕ 25-OH-ВИТАМИНА D У ФУТБОЛИСТОВ В УСЛОВИЯХ СОЛНЕЧНОЙ РАДИАЦИИ УЗБЕКИСТАНА. In Actual Questions and Innovations in Science 2 (pp. 160-161).
4.Mavlyanov, I., Parpiev, S., Sadikov, A., Kurganov, S., & Makhmudov, D. (2020). Relative features of the PPARA (Rs4253778), PPARGC1A (Rs8192678) and PPARG2 (Rs1801282) polymorphisms genes in athletes engaged in cyclic types of sports. European Journal of Molecular and Clinical Medicine, 7(2), 1860-1869.
5.Пирназаров, М. М., Садиков, А. А., Махмудов, Д. Э., & Хегай, Л. Н. (2021). Магнитно-резонансная томографическая визуализация повреждений коленных суставов. Re-health journal, (1 (9)), 152-159.
6.Махмудов, Д. Э., & Саитов, Т. А. (2023). Анализ персонализированного питания высококвалифицированных спортсменов управленческих видов спорта. Klinik va profilaktik tibbiyot jurnali, (3), 79.
7.Махмудов, Д. Э., & Саитов, Т. А. (2023). Анализ персонализированного питания высококвалифицированных спортсменов управленческих видов спорта. Klinik va profilaktik tibbiyot jurnali, (3), 79.
8.Таралева, Т. А., Махмудов, Д. Э., Атабаева, С. М., & Сагитов, Д. М. (2026). ВАРИАБЕЛЬНОСТЬ СЕРДЕЧНОГО РИТМА В ЦИКЛИЧЕСКИХ ВИДАХ СПОРТА: СОВРЕМЕННЫЕ ПОДХОДЫ К ОЦЕНКЕ ФУНКЦИОНАЛЬНОГО СОСТОЯНИЯ СПОРТСМЕНОВ. South Aral Region Medical Journal, 2(Maxsus son-2), 587-593.
9.Махмудов, Д., Абдуллаева, Х., Таралева, Т., Аблялимов, Р., & Парпиев, С. (2025). АНАЛИЗ ФУНКЦИОНАЛЬНЫХ ПОКАЗАТЕЛЕЙ ФУТБОЛИСТОВ НА ЭТАПЕ ОТБОРА К СОРЕВНОВАНИЯМ. Медицина и спорт, (3), 162-162.




United Kingdom
Germany
France
Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo
Italy
Spain
Poland
Netherlands
Belgium
Sweden
Norway
Finland
Denmark
Switzerland
Austria
Czech Republic
Hungary
Romania
Bulgaria
Greece
Portugal